Jeffrey Michael Sobell MD
Associate Professor, Dermatology, Tufts Medical Center
Join to View Full Profile
1244 Boylston StSuite 302Chestnut Hill, MA 02467
Phone+1 617-731-1600
Fax+1 617-731-1601
Dr. Sobell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jeffrey Sobell is a dermatologist in Chestnut Hill, MA and is affiliated with multiple hospitals in the area, including Tufts Medical Center, New England Baptist Hospital, and MelroseWakefield Healthcare. He received his medical degree from University of Virginia School of Medicine and has been in practice 24 years. He is experienced in general dermatology, psoriasis, blistering diseases, and complex medical dermatology. He has more than 20 publications and over 500 citings.
Education & Training
Boston University Medical CenterResidency, Dermatology, 1994 - 1997
University of Virginia Medical CenterInternship, Internal Medicine, 1993 - 1994
University of Virginia School of MedicineClass of 1993
Certifications & Licensure
MA State Medical License 1997 - 2025
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Boston Magazine Castle Connolly, 2010-2013
- Fellow (FAAD) American Academy of Dermatology
Publications & Presentations
PubMed
- Deucravacitinib: Adverse Events of Interest Across Phase 3 Plaque Psoriasis Trials.Joseph F Merola, Laura K Ferris, Jeffrey M Sobell, Howard Sofen, John Osborne
Dermatology and Therapy. 2025-02-01 - 1 citationsPsoriasis adverse events and associated medications as reported in the US Food and Drug Administration's Adverse Event Reporting System from 2016 to 2021.Christine Learned, Sara Alsukait, Sandhya Deverapalli, Erika Elliott, Katherine Moody
JAAD International. 2022-06-01 - 2 citationsDefining drug-free remission of skin disease in patients with plaque psoriasis.April W. Armstrong, Andrew Blauvelt, Jeffrey J. Crowley, Kenneth B. Gordon, Gerald G. Krueger
The British Journal of Dermatology. 2020-06-01
Press Mentions
Pearls to Optimize Safety, Success with BiologicsDecember 5th, 2016
OTEZLA® (Apremilast) Mantiene El Perfil De Seguridad a Largo Plazo en El Tratamiento De Psoriasis Y Artritis Psoriásica, Según Nuevos DatosMarch 11th, 2016- Oral OTEZLA® (Apremilast) Long-Term Safety Data Presented at American Academy of Dermatology CongressMarch 7th, 2016
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
